{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:12:26Z","timestamp":1781716346000,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["09\/0003919 &amp; 15\/0005234"],"award-info":[{"award-number":["09\/0003919 &amp; 15\/0005234"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008664","name":"Juvenile Diabetes Research Foundation United Kingdom","doi-asserted-by":"publisher","award":["9-2010-407 &amp; 3-SRA-2015-36-A-N"],"award-info":[{"award-number":["9-2010-407 &amp; 3-SRA-2015-36-A-N"]}],"id":[{"id":"10.13039\/100008664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.diabres.2019.107789","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T22:02:48Z","timestamp":1563487368000},"page":"107789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12\u202fmonths following diagnosis of type 1 diabetes: An ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) study analysis"],"prefix":"10.1016","volume":"155","author":[{"given":"Anna","family":"Humphreys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Bravis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akaal","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen C.","family":"Walkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian F.","family":"Godsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond G.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick S.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2019.107789_b0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/dme.12048","article-title":"The broad clinical phenotype of Type 1 diabetes at presentation","volume":"30","author":"Merger","year":"2013","journal-title":"Diab Med"},{"key":"10.1016\/j.diabres.2019.107789_b0010","doi-asserted-by":"crossref","first-page":"e020904","DOI":"10.1136\/bmjopen-2017-020904","article-title":"The relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in the ADDRESS UK cohort","volume":"8","author":"Bravis","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.diabres.2019.107789_b0015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2337\/diacare.29.03.06.dc05-1006","article-title":"Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1","volume":"29","author":"Sosenko","year":"2006","journal-title":"Diab Care"},{"key":"10.1016\/j.diabres.2019.107789_b0020","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1210\/jc.2009-1120","article-title":"Latent autoimmune diabetes in adults","volume":"94","author":"Naik","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2019.107789_b0025","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1515\/JPEM.2001.14.4.435","article-title":"Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents","volume":"14","author":"B\u00f6ber","year":"2001","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.diabres.2019.107789_b0030","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/dc08-1987","article-title":"New definition for the partial remission period in children and adolescents With Type 1 diabetes","volume":"32","author":"Mortensen","year":"2009","journal-title":"Diab Care"},{"key":"10.1016\/j.diabres.2019.107789_b0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.18544\/PEDM-22.02.0053","article-title":"The honeymoon phase - what we know today about the factors that can modulate the remission period in type 1 diabetes","volume":"22","author":"Soko\u0142owska","year":"2016","journal-title":"Pediatr Endocrinol Diab Metab"},{"key":"10.1016\/j.diabres.2019.107789_b0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1464-5491.2010.03191.x","article-title":"Proinsulin\/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults","volume":"28","author":"Sch\u00f6lin","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2019.107789_b0045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/diacare.10.2.164","article-title":"Remission in IDDM: prospective study of basal C-peptide and insulin dose in 268 consecutive patients","volume":"10","author":"Agner","year":"1987","journal-title":"Diab Care"},{"key":"10.1016\/j.diabres.2019.107789_b0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1399-543X.2006.00155.x","article-title":"\u201cThe honeymoon phase\u201d in children with type 1 diabetes mellitus: frequency, duration, and influential factors","volume":"7","author":"Abdul-Rasoul","year":"2006","journal-title":"Ped Diab"},{"key":"10.1016\/j.diabres.2019.107789_b0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1365-2796.1999.00426.x","article-title":"Factors predicting clinical remission in adult patients with type 1 diabetes","volume":"245","author":"Sch\u00f6lin","year":"1999","journal-title":"J Intern Med"},{"key":"10.1016\/j.diabres.2019.107789_b0060","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1464-5491.2004.01175.x","article-title":"Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes","volume":"21","author":"Sch\u00f6lin","year":"2004","journal-title":"Diab Med"},{"key":"10.1016\/j.diabres.2019.107789_b0065","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1056\/NEJM198904063201401","article-title":"A comparison of childhood and adult type I diabetes mellitus","volume":"320","author":"Karjalainen","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2019.107789_b0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/adc.80.4.367","article-title":"Partial remission phase of diabetes in children younger than age 10 years","volume":"80","author":"Muhammad","year":"1999","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.diabres.2019.107789_b0075","doi-asserted-by":"crossref","first-page":"e000423","DOI":"10.1136\/bmjdrc-2017-000423","article-title":"Ethnic differences in early glycemic control in childhood-onset type 1 diabetes","volume":"5","author":"Khanolkar","year":"2017","journal-title":"BMJ Open Diab Res Care"},{"key":"10.1016\/j.diabres.2019.107789_b0080","first-page":"851378","article-title":"Characteristics and determinants of partial remission in children with type 1 diabetes using the insulin-dose-adjusted A1C definition","volume":"2014","author":"Pecheur","year":"2014","journal-title":"J Diab Res"},{"key":"10.1016\/j.diabres.2019.107789_b0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1399-5448.2008.00376.x","article-title":"Young children (<5yr) and adolescents (>12yr) with type 1 diabetes mellitus have low rate of partial remission: diabetic ketoacidosis is an important risk factor","volume":"9","author":"Bowden","year":"2008","journal-title":"Pediatric Diab"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2019.107789_b0090","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2337\/diab.27.1.S262","article-title":"Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes","volume":"27","author":"Madsbad","year":"1978","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2019.107789_b0095","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1515\/jpem-2017-0100","article-title":"Markers influencing the presence of partial clinical remission in patients with newly diagnosed type 1 diabetes","volume":"30","author":"Pyziak","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.diabres.2019.107789_b0100","doi-asserted-by":"crossref","first-page":"e013956","DOI":"10.1136\/bmjopen-2016-013956","article-title":"Rationale and protocol for the After Diabetes Diagnosis REsearch Support System (ADDRESS): an incident and high risk type 1 diabetes UK cohort study","volume":"7","author":"Walkey","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.diabres.2019.107789_b0105","article-title":"Integration of routine parameters of glycemic variability in a simple screening method for partial remission in children with type 1 diabetes","volume":"2014","author":"Nielens","year":"2014","journal-title":"J Diab Res"},{"key":"10.1016\/j.diabres.2019.107789_b0110","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.2337\/dc16-0360","article-title":"Fall in C-peptide during first 4 Years from diagnosis of type 1 Diabetes: variable relation to age, HbA1c, and insulin dose","volume":"39","author":"Hao","year":"2016","journal-title":"Diab Care"},{"key":"10.1016\/j.diabres.2019.107789_b0115","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/sj.ijo.0803300","article-title":"Body mass index in children and adolescents: considerations for population-based applications","volume":"30","author":"Must","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.diabres.2019.107789_b0120","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/17477161003615583","article-title":"Defining obesity risk status in the general childhood population: which cut-offs should we use?","volume":"5","author":"de Onis","year":"2010","journal-title":"Int J Pediatr Obes"},{"key":"10.1016\/j.diabres.2019.107789_b0125","doi-asserted-by":"crossref","first-page":"e0176860","DOI":"10.1371\/journal.pone.0176860","article-title":"A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes","volume":"12","author":"Marino","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2019.107789_b0130","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/pedi.12413","article-title":"Factors contributing to partial remission in type 1 diabetes: analysis based on the insulin dose-adjusted HbA1c in 3657 children and adolescents from Germany and Austria","volume":"18","author":"Nagl","year":"2017","journal-title":"Pediatr Diab"},{"key":"10.1016\/j.diabres.2019.107789_b0135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF02624684","article-title":"Remission phase, endogenous insulin secretion and metabolic control in diabetic children","volume":"19","author":"Knip","year":"1982","journal-title":"Acta Diabetol Lat."},{"key":"10.1016\/j.diabres.2019.107789_b0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1464-5491.1992.tb01777.x","article-title":"Clinical and laboratory features of type 1 diabetic children at the time of diagnosis","volume":"9","author":"L\u00e9vy-Marchal","year":"1992","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2019.107789_b0145","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.2337\/diacare.23.9.1326","article-title":"Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes","volume":"23","author":"Sabbah","year":"2000","journal-title":"Diab Care"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719304486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719304486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:51:18Z","timestamp":1777510278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822719304486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":29,"alternative-id":["S0168822719304486"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2019.107789","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12\u202fmonths following diagnosis of type 1 diabetes: An ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) study analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2019.107789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107789"}}